A study assessing safety and efficacy of MD-16 intraocular lens in patients with aphakic eye after cataract surgery

Open label study assessing safety and efficacy of MD-16 intraocular lens in patients with aphakic eye after cataract surgery - Phase III -

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1080223821

Enrollment

Registered

2018-02-05

Start date

2018-02-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Interventions

investigational material(s) Generic name etc : MD-16 (Intraocular lens) INN of investigational material : Therapeutic category code : --- Other Dosage and Administration for Investigational material

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects scheduled to remove the lens by phacoemulsification and aspiration

Exclusion criteria

Exclusion criteria: Subjects with indication for secondary lens implantation Subjects with visual loss induced by causes other than cataract Subjects who judged inappropriate of this study by principal investigator / subinvestigator

Design outcomes

Primary

Measure	Time frame
efficacy Visual acuity after surgery	—

Secondary

Measure	Time frame
safety efficacy Visual acuity, adverse events, etc.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026